These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28262210)

  • 1. Pentraxin 3, a Predicator for 28-Day Mortality in Patients With Septic Shock.
    Jie H; Li Y; Pu X; Ye J
    Am J Med Sci; 2017 Mar; 353(3):242-246. PubMed ID: 28262210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: a prospective controlled study according to the Sepsis-3 definitions.
    Song J; Park DW; Moon S; Cho HJ; Park JH; Seok H; Choi WS
    BMC Infect Dis; 2019 Nov; 19(1):968. PubMed ID: 31718563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentraxin-3 Predicts Short- and Mid-term Mortality in Patients with Sepsis and Septic Shock During Intensive Care Treatment.
    Hamed S; Behnes M; Pauly D; Lepiorz D; Barre M; Becher T; Lang S; Akin I; Borggrefe M; Bertsch T; Hoffmann U
    Clin Lab; 2018 Jun; 64(6):999-1011. PubMed ID: 29945330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Pentraxin 3 as a Predictive Marker of Mortality in Severe Septic Patients Who Received Successful Early Goal-Directed Therapy.
    Kim SB; Lee KH; Lee JU; Ann HW; Ahn JY; Jeon YD; Kim JH; Ku NS; Han SH; Choi JY; Song YG; Kim JM
    Yonsei Med J; 2017 Mar; 58(2):370-379. PubMed ID: 28120568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Source of Circulating Pentraxin 3 in Septic Shock Patients.
    Albert Vega C; Mommert M; Boccard M; Rimmelé T; Venet F; Pachot A; Leray V; Monneret G; Delwarde B; Brengel-Pesce K; Mallet F; Trouillet-Assant S
    Front Immunol; 2018; 9():3048. PubMed ID: 30687307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of detection of pentraxins 3 value combined with measurement of vascular lung water index in prognosis of patients with sepsis].
    Sun R; Wang K; Li F; Yang H; Sun X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Jan; 27(1):48-53. PubMed ID: 25591437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentraxin-3 as a marker of disease severity and risk of death in patients with necrotizing soft tissue infections: a nationwide, prospective, observational study.
    Hansen MB; Rasmussen LS; Garred P; Bidstrup D; Madsen MB; Hyldegaard O
    Crit Care; 2016 Feb; 20():40. PubMed ID: 26880104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers of Necrotising Soft Tissue Infections Aspects of the Innate Immune Response.
    Hansen MB
    Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of plasma pentraxin 3 levels in patients with septic shock admitted to intensive care.
    Perez-San Martin S; Suberviola B; Garcia-Unzueta MT; Lavin BA; Campos S; Santibañez M
    PLoS One; 2020; 15(12):e0243849. PubMed ID: 33301518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentraxin-3 Is a Strong Biomarker of Sepsis Severity Identification and Predictor of 90-Day Mortality in Intensive Care Units via Sepsis 3.0 Definitions.
    Chen H; Li T; Yan S; Liu M; Liu K; Zhang H; Gao M; Xiao X
    Diagnostics (Basel); 2021 Oct; 11(10):. PubMed ID: 34679604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality.
    Mauri T; Bellani G; Patroniti N; Coppadoro A; Peri G; Cuccovillo I; Cugno M; Iapichino G; Gattinoni L; Pesenti A; Mantovani A
    Intensive Care Med; 2010 Apr; 36(4):621-9. PubMed ID: 20119647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentraxin 3: a novel and independent prognostic marker in ischemic stroke.
    Ryu WS; Kim CK; Kim BJ; Kim C; Lee SH; Yoon BW
    Atherosclerosis; 2012 Feb; 220(2):581-6. PubMed ID: 22178425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial.
    Caironi P; Masson S; Mauri T; Bottazzi B; Leone R; Magnoli M; Barlera S; Mamprin F; Fedele A; Mantovani A; Tognoni G; Pesenti A; Gattinoni L; Latini R;
    Eur J Clin Invest; 2017 Jan; 47(1):73-83. PubMed ID: 27864924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased serum pentraxin-3 level predicts poor prognosis in patients with colorectal cancer after curative surgery, a cohort study.
    Liu B; Zhao Y; Guo L
    Medicine (Baltimore); 2018 Oct; 97(40):e11780. PubMed ID: 30290589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum pentraxin-3 and tumor necrosis factor-like weak inducer of apoptosis (TWEAK) predict severity of infections in acute decompensated cirrhotic patients.
    Fan WC; Huang CC; Yang YY; Lin A; Lee KC; Hsieh YC; Fung CP; Hsu HC; Hou MC; Lin HC
    J Microbiol Immunol Infect; 2017 Dec; 50(6):905-914. PubMed ID: 26872435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCSK9 is associated with mortality in patients with septic shock: data from the ALBIOS study.
    Vecchié A; Bonaventura A; Meessen J; Novelli D; Minetti S; Elia E; Ferrara D; Ansaldo AM; Scaravilli V; Villa S; Ferla L; Caironi P; Latini R; Carbone F; Montecucco F;
    J Intern Med; 2021 Feb; 289(2):179-192. PubMed ID: 32686253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of Pentraxin-3 in patients with sepsis and septic shock in accordance with latest sepsis-3 definitions.
    Hamed S; Behnes M; Pauly D; Lepiorz D; Barre M; Becher T; Lang S; Akin I; Borggrefe M; Bertsch T; Hoffmann U
    BMC Infect Dis; 2017 Aug; 17(1):554. PubMed ID: 28793880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma kallistatin in critically ill patients with severe sepsis and septic shock.
    Lin WC; Chen CW; Chao L; Chao J; Lin YS
    PLoS One; 2017; 12(5):e0178387. PubMed ID: 28542440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.
    Suzuki S; Takeishi Y; Niizeki T; Koyama Y; Kitahara T; Sasaki T; Sagara M; Kubota I
    Am Heart J; 2008 Jan; 155(1):75-81. PubMed ID: 18082493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients.
    Muller B; Peri G; Doni A; Torri V; Landmann R; Bottazzi B; Mantovani A
    Crit Care Med; 2001 Jul; 29(7):1404-7. PubMed ID: 11445697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.